Loading...
XASX
ALX
Market cap4.99bUSD
Jul 10, Last price  
5.03AUD
1D
1.62%
1Q
16.17%
Jan 2017
2.24%
IPO
670.06%
Name

Atlas Arteria Group

Chart & Performance

D1W1MN
XASX:ALX chart
P/E
28.13
P/S
45.62
EPS
0.18
Div Yield, %
8.08%
Shrs. gr., 5y
0.03%
Rev. gr., 5y
8.88%
Revenues
160m
+10.34%
121,600,00094,724,00087,460,00089,595,00001,466,0002,212,0002,694,00083,225,000132,378,000167,763,000104,556,000100,515,000118,241,000134,000,000145,000,000160,000,000
Net income
260m
-22.74%
-261,300,000-142,488,000-289,489,000-124,435,0001,423,469,000-50,561,00085,082,000225,109,000519,583,00059,852,000-9,821,000-99,210,000163,697,000266,959,000323,500,000335,900,000259,500,000
CFO
614m
+558.80%
66,952,00044,917,00045,255,00010,904,000-24,554,000-41,723,000-15,576,00018,120,00023,140,000314,628,00025,438,00040,031,000473,499,00084,700,00093,200,000614,000,000
Dividend
Sep 24, 20250.2 AUD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Atlas Arteria Limited specializes in the acquisition, development, and management of toll road assets. Among its key holdings is a 13.4% equity stake in Toll Road Investors Partnership II (TRIP II), the concessionaire responsible for the 22-kilometer Dulles Greenway toll road, situated in Virginia, United States. The company was established in 2009 and operates from its corporate headquarters in Melbourne, Australia. It formally rebranded from Macquarie Atlas Roads Limited to its current name, Atlas Arteria Limited, in May 2018.
URL
https://www.atlasarteria.com/
IPO date
Jan 25, 2010
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT